JPMorgan Chase & Co. Raises IMAX (NYSE:IMAX) Price Target to $48.00

IMAX (NYSE:IMAXGet Free Report) had its price objective hoisted by equities researchers at JPMorgan Chase & Co. from $47.00 to $48.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 14.50% from the company’s previous close.

Several other brokerages have also commented on IMAX. Wedbush reissued an “outperform” rating and set a $46.00 price objective on shares of IMAX in a research report on Monday. The Goldman Sachs Group raised shares of IMAX from a “sell” rating to a “neutral” rating and lifted their price target for the company from $22.00 to $34.00 in a research report on Tuesday, November 25th. Wells Fargo & Company upped their price objective on shares of IMAX from $40.00 to $47.00 and gave the stock an “overweight” rating in a report on Thursday, December 18th. B. Riley Financial reiterated a “buy” rating on shares of IMAX in a report on Monday, December 8th. Finally, Rosenblatt Securities reissued a “buy” rating and issued a $47.00 price target on shares of IMAX in a research report on Tuesday. Ten research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, IMAX presently has a consensus rating of “Moderate Buy” and a consensus target price of $43.00.

View Our Latest Analysis on IMAX

IMAX Stock Performance

Shares of NYSE IMAX traded up $5.40 during midday trading on Thursday, hitting $41.92. 4,216,468 shares of the company traded hands, compared to its average volume of 1,157,336. IMAX has a 12-month low of $20.48 and a 12-month high of $42.46. The firm has a market cap of $2.26 billion, a P/E ratio of 59.04, a P/E/G ratio of 1.91 and a beta of 0.38. The stock has a 50-day moving average price of $36.23 and a 200 day moving average price of $33.81.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in IMAX. Westfield Capital Management Co. LP purchased a new stake in IMAX during the 3rd quarter valued at $53,141,000. Orbis Allan Gray Ltd increased its position in IMAX by 31.7% during the second quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company’s stock valued at $142,960,000 after acquiring an additional 1,230,267 shares during the last quarter. Divisadero Street Capital Management LP purchased a new stake in IMAX during the third quarter valued at $20,975,000. Marsico Capital Management LLC bought a new position in IMAX in the fourth quarter valued at about $18,149,000. Finally, Balyasny Asset Management L.P. purchased a new position in IMAX in the second quarter worth about $12,568,000. 93.51% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about IMAX

Here are the key news stories impacting IMAX this week:

IMAX Company Profile

(Get Free Report)

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.

Further Reading

Analyst Recommendations for IMAX (NYSE:IMAX)

Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.